Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Stuart Edward Henry Lumsden has worked on the following 44 EPO patent applications which have been published in the last five years:

EP13166552

Use of a decorating sheet and of a decorated moulding resin, as well as their methods of production

IPC classification:
B29C 45/14, B32B 27/36, B44C 1/10, B44C 3/04
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
The patent has been granted
EP12807689

DEVELOPING ROLLER

IPC classification:
F16C 13/00, G03G 15/08
Applicant:
Bridgestone Corporation
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12811312

FLUX FOR BRAZING ALUMINUM MATERIALS

IPC classification:
B23K 35/363
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12811007

FLUX FOR BRAZING ALUMINUM MATERIALS

IPC classification:
B23K 35/363
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12822234

IMAGE FORMING DEVICE AND METHOD OF MANUFACTURING SAME

IPC classification:
F16C 13/00, G03G 15/00, G03G 15/08, G03G 15/16, G03G 21/10
Applicant:
Bridgestone Corporation
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12770328

POLYMERS FUNCTIONALIZED WITH LACTONES OR THIOLACTONES CONTAINING A PROTECTED AMINO GROUP

IPC classification:
C08C 19/26, C08C 19/44
Applicant:
Bridgestone Corporation
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13703682

COMBINATION THERAPIES USING LATE SODIUM ION CHANNEL BLOCKERS AND POTASSIUM ION CHANNEL BLOCKERS

IPC classification:
A61K 31/00, A61K 31/14, A61K 31/18, A61K 31/439, A61K 31/4545, A61K 31/506, A61K 31/553, A61P 9/06
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13703675

APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR

IPC classification:
A61K 31/4164, A61K 31/4436, A61P 31/12, C07D 233/56, C07D 401/04, C07D 401/14
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12752415

HEMOGLOBIN-ALBUMIN COMPLEX, AND ARTIFICIAL PLASMA EXPANDER AND ARTIFICIAL OXYGEN CARRIER, EACH CONTAINING SAME

IPC classification:
A61K 38/00, A61K 38/16, A61P 7/00, A61P 7/06, C07K 14/76, C07K 14/765, C07K 14/805, C07K 19/00
Applicant:
Chuo University
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12800226

URETHANE RESIN COMPOSITION AND A CONDUCTIVE ROLLER USING SAME

IPC classification:
C08J 9/00, C08J 9/14, C08J 9/30, C08K 5/103, C08K 5/1515, C08L 75/04, F16C 13/00, G03G 15/00, G03G 15/02
Applicant:
Bridgestone Corporation
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13745989

SWEETENER COMPOSITIONS CONTAINING REBAUDIOSIDE B

IPC classification:
A23L 1/236, A23L 2/60, A61K 36/42
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP15158887

Novel modulators of sphingosine phosphate receptors

IPC classification:
A01N 43/82, A61K 31/41, C07D 271/06, C07D 401/04, C07D 413/04, C07D 413/14, C07D 471/04
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP13818940

SUBSTITUTED PYRIDINE-2-CARBOXAMIDE COMPOUNDS AS APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS

IPC classification:
A61K 31/4439, A61P 25/00, A61P 29/00, C07D 417/14
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
PATENT GRANTED
EP15168201

COMPOSITION FOR TREATING A PULMONARY HYPERTENSION

IPC classification:
A61K 31/4985, A61K 31/505, A61K 31/519, A61K 31/53, A61P 9/12, C07D 239/04
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP15177709

STEVIA BLENDS CONTAINING REBAUDIOSIDE B

IPC classification:
A23L 1/236, A23L 2/60
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14721678

USES OF SOLUBLE CORN FIBER FOR INCREASING COLONIC BACTERIA POPULATIONS AND INCREASING MINERAL ABSORPTION

IPC classification:
A23L 29/20, A23L 33/10, A23L 33/21, A23L 33/16
Applicant:
Purdue Research Foundation (PRF)
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14712107

FIBER-CONTAINING CARBOHYDRATE COMPOSITION

IPC classification:
C07H 3/06, C12P 19/04, C13K 13/00, A23L 33/21
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15184883

N-[4-(2-OXO-1,2-DIHYDRO-PYRIDIN-4-YL)-BENZYL]-BENZAMIDE DERIVATIVES AS ALDH-2 INHIBITORS FOR THE TREATMENT OF ADDICTION

IPC classification:
A61K 31/4418, A61P 25/30, A61P 25/32, A61P 25/34, A61P 25/36, C07D 213/64
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
The patent has been granted
EP15177723

OXAZEPINES AS ION CHANNEL MODULATORS

IPC classification:
A61K 31/553, A61P 9/10, C07D 267/14, C07D 413/04, C07D 413/12, C07D 413/14, C07D 498/04
Applicant:
Gilead Sciences Inc
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
The patent has been granted
EP14807674

PHOSPHOR AND METHOD FOR PRODUCING SAME

IPC classification:
C09K 11/08, C09K 11/67, C09K 11/70, C09K 11/88
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14750949

COMPOUND AND METHODS FOR TREATING LONG QT SYNDROME

IPC classification:
A61K 31/506, A61P 9/06
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14847888

METHOD FOR PRODUCING INGOT AND POWDER OF ZIRCONIUM CARBIDE

IPC classification:
C01B 31/30, C04B 35/653
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14752964

PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE AND DRONEDARONE

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/24, A61K 31/343, A61K 31/495
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14750903

METHOD OF TREATING HYPERTROPHIC CARDIOMYOPATHY

IPC classification:
A61K 31/506, A61P 9/06
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP16156595

CARBOHYDRATE COMPOSITIONS

IPC classification:
A23L 33/21, A23L 29/30
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14854240

ZIRCONIUM OXIDE-TITANIUM OXIDE COMPOSITE SOL AND PRODUCTION METHOD THEREOF

IPC classification:
C01G 25/00
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14759436

PROCESS FOR PREPARING DRONEDARONE AND SALTS THEREOF

IPC classification:
C07D 307/80
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
The patent has been granted
EP14878824

METHOD FOR PRODUCING AQUEOUS ZIRCONIUM CHLORIDE SOLUTION

IPC classification:
C01G 25/04
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14887678

CERIUM-ZIRCONIUM-BASED COMPOSITE OXIDE AND METHOD FOR PRODUCING SAME

IPC classification:
B01J 23/10, B01J 23/34, B01J 23/72, B01J 23/745, B01J 23/75, B01J 23/755, C01G 25/00, C01G 45/00, C01G 49/00, C01G 51/00, C01G 53/00
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14824313

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

IPC classification:
A61K 31/536, A61P 9/00, C07D 413/06, C07D 417/06
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14824288

APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS

IPC classification:
A61K 31/4439, A61P 25/00, A61P 29/00, C07D 417/14
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16169333

FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS

IPC classification:
A61K 31/5513, A61K 31/553, A61K 31/554, C07D 243/24, C07D 267/14, C07D 291/08, C07D 403/06, C07D 413/06, C07D 413/12, C07D 413/14, C07D 419/06, C07D 471/04, C07D 487/04, C07D 498/04
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
Request for examination was made
EP14819206

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

IPC classification:
A61K 31/4155, A61K 31/506, A61P 3/10, A61P 25/04, C07D 261/20, C07D 413/12, C07D 417/12, C07D 471/04
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16169320

FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS

IPC classification:
A61K 31/553, A61P 9/10, C07D 267/14, C07D 413/04, C07D 413/12, C07D 413/14, C07D 498/04
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
Request for examination was made
EP16180014

USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS

IPC classification:
A61K 9/00, A61K 9/02, A61K 31/40, A61K 31/403, A61K 31/522, A61K 45/06, A61K 47/06, A61P 9/00, A61P 9/04, A61P 9/10
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
APPLICATION PUBLISHED
EP16180914

COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/48, A61K 31/422, A61K 31/4985, A61K 31/503, A61K 31/505, A61K 31/519, A61P 9/00, A61P 9/10, A61P 9/12, A61P 11/00, A61P 11/06, A61P 13/12
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
Request for examination was made
EP15707464

SOLID FORMS OF AN ION CHANNEL MODULATOR

IPC classification:
A61K 31/553, A61P 9/00, C07D 413/06
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15782461

METHOD FOR PRODUCING GARNET-TYPE COMPOUND, GARNET-TYPE COMPOUND, AND ALL-SOLID LITHIUM SECONDARY CELL CONTAINING SAID GARNET-TYPE COMPOUND

IPC classification:
C01G 25/00, C01G 27/00, C01G 33/00, H01M 4/62, H01M 10/052, H01M 10/0562
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16195735

SUBSTITUTED PYRIDINE-2-CARBOXAMIDE COMPOUNDS AS APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS

IPC classification:
A61K 31/4439, A61P 25/00, A61P 29/00, C07D 417/14
Applicant:
Gilead Sciences Inc
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
APPLICATION PUBLISHED
EP15802353

IMMUNOREGULATORY AGENTS

IPC classification:
A61K 31/15, A61K 31/155, C07C 259/12
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15834841

SYRINGE ACCESSORY

IPC classification:
A61M 5/14, A61M 5/178
Agent:
Stuart Edward Henry Lumsden, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15862635

4-FLUORO-THIO-CONTAINING INHIBITORS OF APP2, COMPOSITIONS THEREOF AND METHOD OF USE

IPC classification:
A01N 43/38
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
Request for examination was made
EP15805525

MILK- BASED EXTRUDED SNACK

IPC classification:
A23C 9/00, A23G 3/46, A23G 3/54, A23L 7/10, A23P 20/00, A23P 30/20, A23L 7/117, A23L 7/17
Applicant:
Nestec S.A.
Agent:
Stuart Edward Henry Lumsden, Nestec S.A.
Status:
Request for examination was made
EP15805546

EXTRUDED WHOLE-GRAIN CEREAL PRODUCTS AND THEIR PROCESS OF MAKING

IPC classification:
A23K 10/00, A23L 7/00, A23L 7/10, A23P 30/20
Applicant:
Nestec S.A.
Agent:
Stuart Edward Henry Lumsden, Nestec S.A.
Status:
Request for examination was made

Please Sign in to use this feature